-
Sector Analysis
Digital Biomarkers Market Size, Share and Trends Analysis by Region, Product Type (Wearable Application, Mobile Application, Portables), End-user (Healthcare Companies and Services, Others), and Segment Forecast, 2022-2027
The digital biomarkers market size was valued at US$2.32 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 25.7% during 2022-2027. The key to the digital biomarkers market growth has been the aging population and rise in chronic diseases, increasing investments and funding to develop digital biomarkers, and increasing role of digital biomarkers in clinical trials. Additionally, key strategic partnerships and mergers and acquisitions are expected to accelerate market growth. Over the forecast...
-
Thematic Analysis
Virtual Clinical Trials – Thematic Research
Virtual clinical trials, also commonly referred to as decentralized clinical trials (DCTs), use digital technologies and other processes that differ from traditional trial models to bring research closer to patient’s homes in order to increase access to trials, as well as reduce inconvenience and burden on participants by decreasing the number of physical site visits. Virtual trials are also known as remote, siteless, hybrid, or digital trials. The examples of digital technologies used in virtual trials includes eConsent, telemedicine, electronic...